Pfizer Inc said on Monday it would buy drug developer Arena Pharmaceuticals for $6.7 billion in cash, to add a promising treatment candidate that targets diseases affecting the stomach and intestine.
for $6.7 billion in cash, to add a promising treatment candidate that targets diseases affecting the stomach and intestine.
This is the latest deal Pfizer has struck this year to expand treatment pipeline. The company last month acquired immuno-oncology company Trillium Therapeutics Inc for about $2.22 billion to strengthen its arsenal of blood cancer therapies.Arena is developing several treatments for gastroenterology, dermatology and cardiology.
"The proposed acquisition of Arena complements our capabilities and expertise in inflammation and immunology," Pfizer executive Mike Gladstone said, adding the company plans to accelerate the clinical development of etrasimod.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer to acquire Arena Pharmaceuticals in deal valued at about $6.7 billionPfizer Inc. undefined said Monday it has agreed to acquire Arena Pharmaceuticals Inc. undefined in a deal with a value of about $6.7 billion. The news sent...
Weiterlesen »
Pfizer Booster Shots Are Effective Against Omicron Variant, Israeli Study SaysPeople who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found
Weiterlesen »
Pfizer to acquire Arena Pharmaceuticals in deal valued at about $6.7 billionPfizer Inc. undefined said Monday it has agreed to acquire Arena Pharmaceuticals Inc. undefined in a deal with a value of about $6.7 billion. The news sent...
Weiterlesen »
Harley's electric motorcycle division to go public via $1.7 bln SPAC dealHarley-Davidson Inc's electric-motorcycle division LiveWire will go public through a merger with a blank-check firm in a deal valuing it at $1.77 billion, the company said on Monday, as the 118-year old brand turns to younger customers to boost volumes.
Weiterlesen »
South African president tests positive for COVID, mildly illSouth African President Cyril Ramaphosa is receiving treatment for mild COVID-19 symptoms after testing positive for the disease.
Weiterlesen »
One year after FDA authorized Pfizer's COVID vaccine, cases are on the riseSaturday marks one year since the Food and Drug Administration authorized Pfizer's COVID-19 vaccine — the first of three COVID-19 vaccines now in use in the United States.
Weiterlesen »